The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
From Original Antigenic Sin to the Universal Influenza Virus Vaccine
Open accessAbstract
Antibody responses are essential for protection against influenza virus infection. Humans are exposed to a multitude of influenza viruses throughout their lifetime and it is clear that immune history influences the magnitude and quality of the antibody response. The “original antigenic sin” (OAS) concept refers to the impact of the first influenza virus variant encounter on lifelong immunity. Although this model has been challenged since its discovery, past exposure, and likely one's first exposure, clearly affects the epitopes targeted in subsequent responses. Understanding how previous exposure to influenza virus shape antibody responses to vaccination and infection is critical, especially with the prospect of future pandemics and for the effective development of a universal influenza vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New World Bats Harbor Diverse Influenza A Viruses
Tong, S., Zhu, X., Li, Y., Shi, M., Zhang, J., Bourgeois, M., Yang, H., Chen, X., Recuenco, S., Gomez, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003657 · Cited by 1,351
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326
Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus
Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R., Gargiullo, P. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906453 · Cited by 1,259
Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203
Sui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L.-M., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,130
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
Wrammert, J., Smith, K., Miller, J., Langley, W. A., Kokko, K., Larsen, C., Zheng, N.-Y., Mays, I., Garman, L., Helms, C., et al. (2008) · Nature · doi:10.1038/nature06890 · Cited by 1,025
Self-citationHighly Conserved Protective Epitopes on Influenza B Viruses
Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V., Jongeneelen, M., et al. (2012) · Science · doi:10.1126/science.1222908 · Cited by 866
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M., Yu, W., Ophorst, C., Cox, F., Korse, H. J. W. M., Brandenburg, B., et al. (2011) · Science · doi:10.1126/science.1204839 · Cited by 822
Wrammert, J., Koutsonanos, D., Li, G.-M., Edupuganti, S., Sui, J., Morrissey, M., McCausland, M., Skountzou, I., Hornig, M., Lipkin, W. I., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101352 · Cited by 777
Self-citationHemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
Yassine, H. M., Boyington, J. C., McTamney, P. M., Wei, C.-J., Kanekiyo, M., Kong, W.-P., Gallagher, J. R., Wang, L., Zhang, Y., Joyce, M. G., et al. (2015) · Nature Medicine · doi:10.1038/nm.3927 · Cited by 699
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
Impagliazzo, A., Milder, F., Kuipers, H., Wagner, M. V., Zhu, X., Hoffman, R. M. B., van Meersbergen, R., Huizingh, J., Wanningen, P., Verspuij, J., et al. (2015) · Science · doi:10.1126/science.aac7263 · Cited by 600
Advances in the development of influenza virus vaccines
Krammer, F., & Palese, P. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4529 · Cited by 597
Self-citationDISQUISITIONS ON ORIGINAL ANTIGENIC SIN
de St.Groth, S. F., & Webster, R. G. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.124.3.331 · Cited by 567
Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983
Rota, P. A., Wallis, T. R., Harmon, M. W., Rota, J. S., Kendal, A. P., & Nerome, K. (1990) · Virology · doi:10.1016/0042-6822(90)90186-u · Cited by 539 · cited 1×
“Influenza B viruses are classified as a single influenza virus type, but two antigenically and genetically distinct lineages circulate, the Victoria-like and the Yamagata-like lineage [5].”
BackgroundInfluenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
Steel, J., Lowen, A. C., Wang, T. T., Yondola, M., Gao, Q., Haye, K., García-Sastre, A., & Palese, P. (2010) · mBio · doi:10.1128/mbio.00018-10 · Cited by 533
The annual production cycle for influenza vaccine
Gerdil, C. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00071-9 · Cited by 529
Cross-neutralization of influenza A viruses mediated by a single antibody loop
Ekiert, D. C., Kashyap, A. K., Steel, J., Rubrum, A., Bhabha, G., Khayat, R., Lee, J. H., Dillon, M. A., O’Neil, R. E., Faynboym, A. M., et al. (2012) · Nature · doi:10.1038/nature11414 · Cited by 481
Antibody landscapes after influenza virus infection or vaccination
Fonville, J. M., Wilks, S. H., James, S. L., Fox, A., Ventresca, M., Aban, M., Xue, L., Jones, T. C., H., L. N. M., T., P. Q., et al. (2014) · Science · doi:10.1126/science.1256427 · Cited by 474
Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting
Gostic, K. M., Ambrose, M., Worobey, M., & Lloyd-Smith, J. O. (2016) · Science · doi:10.1126/science.aag1322 · Cited by 462
Whittle, J. R. R., Zhang, R., Khurana, S., King, L. R., Manischewitz, J., Golding, H., Dormitzer, P. R., Haynes, B. F., Walter, E. B., Moody, M. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111497108 · Cited by 439
Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
Kallewaard, N. L., Corti, D., Collins, P. J., Neu, U., McAuliffe, J. M., Benjamin, E., Wachter-Rosati, L., Palmer-Hill, F. J., Yuan, A. Q., Walker, P. A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.073 · Cited by 426
Krammer, F., Pica, N., Hai, R., Margine, I., & Palese, P. (2013) · Journal of Virology · doi:10.1128/jvi.00641-13 · Cited by 423
Self-citationImmune history profoundly affects broadly protective B cell responses to influenza
Andrews, S. F., Huang, Y., Kaur, K., Popova, L. I., Ho, I. Y., Pauli, N. T., Dunand, C. J. H., Taylor, W. M., Lim, S., Huang, M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad0522 · Cited by 411
Self-citationBroadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection
DiLillo, D. J., Palese, P., Wilson, P. C., & Ravetch, J. V. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84428 · Cited by 407
Self-citationDavenport, F. M., Hennessy, A. V., Francis, T., & Fabisch, W. T. T. A. O. P. (1953) · Journal of Experimental Medicine · doi:10.1084/jem.98.6.641 · Cited by 399
Li, G.-M., Chiu, C., Wrammert, J., McCausland, M., Andrews, S. F., Zheng, N.-Y., Lee, J.-H., Huang, M., Qu, X., Edupuganti, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118979109 · Cited by 393
Self-citationVaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses
Joyce, M. G., Wheatley, A. K., Thomas, P. V., Chuang, G.-Y., Soto, C., Bailer, R. T., Druz, A., Georgiev, I. S., Gillespie, R. A., Kanekiyo, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.043 · Cited by 333
Influenza virus hemagglutinin stalk-based antibodies and vaccines
Krammer, F., & Palese, P. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.07.007 · Cited by 326
Self-citationGenesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus
Worobey, M., Han, G.-Z., & Rambaut, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324197111 · Cited by 286
Wang, T. T., Tan, G. S., Hai, R., Pica, N., Petersen, E., Moran, T. M., & Palese, P. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000796 · Cited by 278
Original Antigenic Sin Responses to Influenza Viruses
Kim, J. H., Skountzou, I., Compans, R., & Jacob, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900398 · Cited by 274
Henry Dunand, C. J., Leon, P. E., Huang, M., Choi, A., Chromikova, V., Ho, I. Y., Tan, G. S., Cruz, J., Hirsh, A., Zheng, N.-Y., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.05.014 · Cited by 268
Self-citationSchmidt, A. G., Xu, H., Khan, A. R., O’Donnell, T., Khurana, S., King, L. R., Manischewitz, J., Golding, H., Suphaphiphat, P., Carfi, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218256109 · Cited by 246
Immune history and influenza virus susceptibility
Cobey, S., & Hensley, S. E. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.12.004 · Cited by 244
Evidence for Antigenic Seniority in Influenza A (H3N2) Antibody Responses in Southern China
Lessler, J., Riley, S., Read, J. M., Wang, S., Zhu, H., Smith, G. J. D., Guan, Y., Jiang, C. Q., & Cummings, D. A. T. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002802 · Cited by 243
Ellebedy, A. H., Krammer, F., Li, G.-M., Miller, M. S., Chiu, C., Wrammert, J., Chang, C. Y., Davis, C. W., McCausland, M., Elbein, R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414070111 · Cited by 234
Self-citationLinderman, S. L., Chambers, B. S., Zost, S. J., Parkhouse, K., Li, Y., Herrmann, C., Ellebedy, A. H., Carter, D. M., Andrews, S. F., Zheng, N.-Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409171111 · Cited by 222
Self-citationHemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses
Margine, I., Krammer, F., Hai, R., Heaton, N. S., Tan, G. S., Andrews, S. A., Runstadler, J. A., Wilson, P. C., Albrecht, R. A., García-Sastre, A., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01715-13 · Cited by 197
Self-citationMallajosyula, V. V. A., Citron, M., Ferrara, F., Lu, X., Callahan, C., Heidecker, G. J., Sarma, S. P., Flynn, J. A., Temperton, N. J., Liang, X., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402766111 · Cited by 191
Miller, M. S., Gardner, T. J., Krammer, F., Aguado, L. C., Tortorella, D., Basler, C. F., & Palese, P. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006637 · Cited by 190
Self-citationPrevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands
Bodewes, R., de Mutsert, G., van der Klis, F. R. M., Ventresca, M., Wilks, S., Smith, D. J., Koopmans, M., Fouchier, R. A. M., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00396-10 · Cited by 185
Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus.
Air, G. M. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7639 · Cited by 184
Immune history shapes specificity of pandemic H1N1 influenza antibody responses
Li, Y., Myers, J. L., Bostick, D. L., Sullivan, C. B., Madara, J., Linderman, S. L., Liu, Q., Carter, D. M., Wrammert, J., Esposito, S., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130212 · Cited by 184
Self-citationUniversal influenza virus vaccines and therapeutic antibodies
Nachbagauer, R., & Krammer, F. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.02.009 · Cited by 184
Self-citationA common solution to group 2 influenza virus neutralization
Friesen, R. H. E., Lee, P. S., Stoop, E. J. M., Hoffman, R. M. B., Ekiert, D. C., Bhabha, G., Yu, W., Juraszek, J., Koudstaal, W., Jongeneelen, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319058110 · Cited by 182
Krystal, M., Elliott, R. M., Benz, E. W., Young, J. F., & Palese, P. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.15.4800 · Cited by 180
Lee, P. S., Yoshida, R., Ekiert, D. C., Sakai, N., Suzuki, Y., Takada, A., & Wilson, I. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212371109 · Cited by 179
Monto, A. S. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.066 · Cited by 173
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins
Nachbagauer, R., Choi, A., Hirsh, A., Margine, I., Iida, S., Barrera, A., Ferres, M., Albrecht, R. A., García-Sastre, A., Bouvier, N. M., et al. (2017) · Nature Immunology · doi:10.1038/ni.3684 · Cited by 172
Self-citationMoody, M. A., Zhang, R., Walter, E. B., Woods, C. W., Ginsburg, G. S., McClain, M. T., Denny, T. N., Chen, X., Munshaw, S., Marshall, D. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025797 · Cited by 165
Zhu, X., Yu, W., McBride, R., Li, Y., Chen, L.-M., Donis, R. O., Tong, S., Paulson, J. C., & Wilson, I. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218509110 · Cited by 165
Rajendran, M., Nachbagauer, R., Ermler, M. E., Bunduc, P., Amanat, F., Izikson, R., Cox, M. M. J., Palese, P., Eichelberger, M. C., & Krammer, F. (2017) · mBio · doi:10.1128/mbio.02281-16 · Cited by 165
Self-citationMargine, I., Hai, R., Albrecht, R. A., Obermoser, G., Harrod, A. C., Banchereau, J., Palucka, K., García-Sastre, A., Palese, P., Treanor, J. J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.03509-12 · Cited by 163
Self-citationA Pan-H1 Anti-Hemagglutinin Monoclonal Antibody with Potent Broad-Spectrum Efficacy In Vivo
Tan, G. S., Krammer, F., Eggink, D., Kongchanagul, A., Moran, T. M., & Palese, P. (2012) · Journal of Virology · doi:10.1128/jvi.00469-12 · Cited by 161
Self-citationEstimating the Life Course of Influenza A(H3N2) Antibody Responses from Cross-Sectional Data
Kucharski, A. J., Lessler, J., Read, J. M., Zhu, H., Jiang, C. Q., Guan, Y., Cummings, D. A. T., & Riley, S. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002082 · Cited by 159
Induction of Broadly Reactive Anti-Hemagglutinin Stalk Antibodies by an H5N1 Vaccine in Humans
Nachbagauer, R., Wohlbold, T. J., Hirsh, A., Hai, R., Sjursen, H., Palese, P., Cox, R. J., & Krammer, F. (2014) · Journal of Virology · doi:10.1128/jvi.02133-14 · Cited by 152
Self-citationNachbagauer, R., Choi, A., Izikson, R., Cox, M. M. J., Palese, P., & Krammer, F. (2016) · mBio · doi:10.1128/mbio.01996-15 · Cited by 151
Self-citationGraves, P. N., Schulman, J. L., Young, J. F., & Palese, P. (1983) · Virology · doi:10.1016/0042-6822(83)90465-8 · Cited by 142
Focused antibody response to influenza linked to antigenic drift
Huang, K.-Y. A., Rijal, P., Schimanski, L. M., Powell, T. J., Lin, T., McCauley, J. W., Daniels, R. S., & Townsend, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81104 · Cited by 142
Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti-Influenza A Antibodies
Sui, J., Sheehan, J., Hwang, W. C., Bankston, L. A., Burchett, S. K., Huang, C.-Y., Liddington, R., Beigel, J. H., & Marasco, W. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir121 · Cited by 129
Stalking influenza by vaccination with pre-fusion headless HA mini-stem
Valkenburg, S. A., Mallajosyula, V. V. A., Li, O. T. W., Chin, A. W. H., Carnell, G., Temperton, N. J., Varadarajan, R., & Poon, L. L. M. (2016) · Scientific Reports · doi:10.1038/srep22666 · Cited by 126
Preexisting human antibodies neutralize recently emerged H7N9 influenza strains
Henry, C., Leon, P. E., Kaur, K., Tan, G. S., Zheng, N., Andrews, S., Huang, M., Qu, X., Huang, Y., Ferrer, M. S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74374 · Cited by 124
Self-citationTan, G. S., Lee, P. S., Hoffman, R. M. B., Mazel‐Sanchez, B., Krammer, F., Leon, P. E., Ward, A. B., Wilson, I. A., & Palese, P. (2014) · Journal of Virology · doi:10.1128/jvi.02289-14 · Cited by 121
Self-citationAndrews, S. F., Kaur, K., Pauli, N. T., Huang, M., Huang, Y., & Wilson, P. C. (2015) · Journal of Virology · doi:10.1128/jvi.02871-14 · Cited by 120
Self-citationKrammer, F., Palese, P., & Steel, J. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_408 · Cited by 117
Self-citationThomson, C. A., Wang, Y., Jackson, L. M., Olson, M., Wang, W., Liavonchanka, A., Keleta, L., da Silva, V. G. L., Diederich, S., Jones, R. B., et al. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00087 · Cited by 114
H3 Stalk-Based Chimeric Hemagglutinin Influenza Virus Constructs Protect Mice from H7N9 Challenge
Krammer, F., Margine, I., Hai, R., Flood, A., Hirsh, A., Tsvetnitsky, V., Chen, D., & Palese, P. (2013) · Journal of Virology · doi:10.1128/jvi.03183-13 · Cited by 113
Self-citationNovel universal influenza virus vaccine approaches
Krammer, F. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.02.002 · Cited by 106
Self-citationBodewes, R., Kreijtz, J. H. C. M., Geelhoed-Mieras, M. M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02371-10 · Cited by 101
Age- and Sex-Specific Mortality Associated With the 1918–1919 Influenza Pandemic in Kentucky
Viboud, C. G., Eisenstein, J., Reid, A. H., Janczewski, T. A., Morens, D. M., & Taubenberger, J. K. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis745 · Cited by 92
Tsibane, T., Ekiert, D. C., Krause, J. C., Martinez, O., Crowe, J. E., Wilson, I. A., & Basler, C. F. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003067 · Cited by 89
Masking of antigenic epitopes by antibodies shapes the humoral immune response to influenza
Zarnitsyna, V. I., Ellebedy, A. H., Davis, C. W., Jacob, J., Ahmed, R., & Antia, R. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0248 · Cited by 86
Wohlbold, T. J., Nachbagauer, R., Margine, I., Tan, G. S., Hirsh, A., & Krammer, F. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.038 · Cited by 83
Self-citationConserved Neutralizing Epitope at Globular Head of Hemagglutinin in H3N2 Influenza Viruses
Iba, Y., Fujii, Y., Ohshima, N., Sumida, T., Kubota‐Koketsu, R., Ikeda, M., Wakiyama, M., Shirouzu, M., Okada, J., Okuno, Y., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00420-14 · Cited by 83
Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in Ferrets
Nachbagauer, R., Miller, M. S., Hai, R., Ryder, A. B., Rose, J. K., Palese, P., García‐Sastre, A., Krammer, F., & Albrecht, R. A. (2015) · Journal of Virology · doi:10.1128/jvi.02481-15 · Cited by 81
Self-citation1976 and 2009 H1N1 Influenza Virus Vaccines Boost Anti-Hemagglutinin Stalk Antibodies in Humans
Miller, M. S., Tsibane, T., Krammer, F., Hai, R., Rahmat, S., Basler, C. F., & Palese, P. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis652 · Cited by 77
Self-citationLinderman, S. L., & Hensley, S. E. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005806 · Cited by 68
Petrie, J. G., Parkhouse, K., Ohmit, S. E., Malosh, R. E., Monto, A. S., & Hensley, S. E. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw479 · Cited by 65
Sangster, M. Y., Baer, J., Santiago, F. W., Fitzgerald, T. F., Ilyushina, N. A., Sundararajan, A., Henn, A. D., Krammer, F., Yang, H., Luke, C. J., et al. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00735-12 · Cited by 60
Self-citationAn H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in Humans
Krammer, F., Jul‐Larsen, Å., Margine, I., Hirsh, A., Sjursen, H., Zambon, M. C. F. A., & Cox, R. J. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00272-14 · Cited by 52
Self-citationGulati, U., Kumari, K., Wu, W., Keitel, W. A., & Air, G. M. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.08.053 · Cited by 51
Halliley, J. L., Khurana, S., Krammer, F., Fitzgerald, T. F., Coyle, E. M., Chung, K. Y., Baker, S. F., Yang, H., Martínez‐Sobrido, L., Treanor, J. J., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv210 · Cited by 45
Self-citationSkehel, J. J., & Wiley, D. C. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00131-7 · Cited by 38
Liu, L., Nachbagauer, R., Zhu, L., Huang, Y., Xie, X., Jin, S., Zhang, A., Wan, Y., Hirsh, A., Tian, D., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw608 · Cited by 35
Self-citationO'Donnell, C. D., Wright, A. R., Vogel, L., et al. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00790-13 · Cited by 20
Cited by
Krammer, F., Smith, G. J. D., Fouchier, R. A. M., Peiris, M., Kedzierska, K., Doherty, P. C., Palese, P., Shaw, M. L., Treanor, J., Webster, R. G., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0002-y · Cited by 1,570
Self-citationEmerging concepts in the science of vaccine adjuvants
Pulendran, B., S. Arunachalam, P., & O’Hagan, D. T. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00163-y · Cited by 1,385
Cancro, M. P. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-092419-031130 · Cited by 464
Designing spatial and temporal control of vaccine responses
Roth, G. A., Picece, V. C. T. M., Ou, B. S., Luo, W., Pulendran, B., & Appel, E. A. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00372-2 · Cited by 316
Mucosal immune responses to infection and vaccination in the respiratory tract
Mettelman, R. C., Allen, E. K., & Thomas, P. G. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.013 · Cited by 271
Metadata
- Authors
- Henry, C., Palm, A.-K. E., Krammer, F., & Wilson, P. C.
- Venue
- Trends in Immunology
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 39
- Issue
- 1
- Pages
- 70-79
- ISSN
- 1471-4906 (ISSN-L)
- OpenAlex
- W2751019848
- Cited by
- 261
- References
- 85
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.